[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339248-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339248-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","loss-of-y-in-regulatory-t-lymphocytes-in-the-tumor-micro-environment-of-primary-colorectal-cancers-and-liver-metastases","Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases","","Male sex increases colorectal cancer (CRC) risk, with heavier disease burden and earlier onset. This study tests whether loss of chromosome Y (LOY) within the tumor micro-environment (TME) contributes to oncogenesis. Frequency and functional effects of LOY were examined in blood, TME, and non-tumorous tissues. Regulatory T lymphocytes (Tregs) in the TME showed the highest LOY frequency (22%). LOY scores from scRNA-seq correlated with elevated PDCD1, TIGIT, and IKZF2, suggesting an influence on Treg suppressive programs and potential impact on immunotherapy response in CRC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/loss-of-y-in-regulatory-t-lymphocytes-in-the-tumor-micro-environment-of-primary-colorectal-cancers-and-liver-metastases/339248/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/loss-of-y-in-regulatory-t-lymphocytes-in-the-tumor-micro-environment-of-primary-colorectal-cancers-and-liver-metastases/339248.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about colorectal cancer?","Question",{"text":63,"@type":64},"It examines whether loss of chromosome Y (LOY) in the tumor micro-environment contributes to colorectal cancer development.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which immune cell population showed the highest LOY frequency in the tumor micro-environment?",{"text":68,"@type":64},"Regulatory T lymphocytes (Tregs) in the tumor micro-environment had the highest LOY frequency, reported as 22%.",{"name":70,"@type":61,"acceptedAnswer":71},"How is LOY related to immune checkpoint signaling in Tregs?",{"text":72,"@type":64},"An LOY score from scRNA-seq correlated with higher expression of PDCD1 and TIGIT (immune checkpoint receptors), along with IKZF2 in Tregs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339248,1790591269,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nLoss of Y in regulatory T lymphocytes in the tumor micro‑environment of primary colorectal cancers and liver metastases  \nMagdalena Wójcik1,10, Ulana Juhas1,2,10, Elyas Mohammadi1,10, Jonas Mattisson 3, Kinga Drężek‑Chyła1, Edyta Rychlicka‑Buniowska1, Bożena Bruhn‑Olszewska3, Hanna Davies3, Katarzyna Chojnowska1, Paweł Olszewski1, Michał Bieńkowski4,  \nMichał Jankowski5,6, Olga Rostkowska7, Andrzej Hellmann7, Rafał Pęksa4, Jacek Kowalski4, Marek Zdrenka8, Jarek Kobiela7, Wojciech Zegarski5,6, Wojciech Biernat4, Łukasz Szylberg8,9,  \nPiotr Remiszewski7, Jakub Mieczkowski1, Natalia Filipowicz1,11* & Jan P. Dumanski1,3,11* Male sex is a risk factor for colorectal cancer (CRC) with higher illness burden and earlier onset.  \nThus, we hypothesized that loss of chromosome Y (LOY) in the tumor micro‑environment (TME) might be involved in oncogenesis. Previous studies show that LOY in circulating leukocytes of aging men was associated with shorter survival and non‑hematological cancer, as well as higher LOY in CD4 +T‑lymphocytes in men with prostate cancer vs. controls. However, nothing is known about LOY in leukocytes infiltrating TME and we address this aspect here. We studied frequency and functional effects of LOY in blood, TME and non‑tumorous tissue. Regulatory T‑lymphocytes (Tregs) inTME had the highest frequency of LOY (22%) in comparison to CD4 +T‑lymphocytes and cytotoxic CD8 +T‑lymphocytes. LOY score using scRNA‑seq was also linked to higher expression of PDCD1, TIGITand IKZF2 in Tregs. PDCD1 and TIGIT encode immune checkpoint receptors involved in the regulation of Tregs function. Our study sets the direction for further functional research regarding a probable role of LOY in intensifying features related to the suppressive phenotype ofTregs inTME and consequently a possible influence on immunotherapy response in CRC patients.  \nColorectal cancer (CRC) is one of the leading contributors to cancer-related morbidity and mortality worldwide1. The liver is a main site of metastases from primary tumors ofCRCs, likely due to direct blood drainage through portal system. Consequently, about 50% ofCRC patients develop synchronous or metachronous liver metastases (LM_CRC)2, which frequently leads to the death of the patient3. Observations ofCRC cohorts conducted for over the past 25 years indicate that CRC shows pronounced sexual dimorphism4. Male sex is a risk factor for CRC, with higher illness burden, and earlier onset and metastatic disease, of which ~ 30% are synchronous with CRC diagnosis4. Mutations in numerous genes have been associated with CRC risk, development of recurrence and  \n13P-Medicine Laboratory, Medical University of Gdańsk, Dębinki 7, 80-211 Gdańsk, Poland. 2Department of Bioenergetics and Physiology of Exercise, Medical University of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland. 3Department of Immunology, Genetics and Pathology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. 4Department of Pathomorphology, Medical University of Gdańsk, Gdańsk, Poland. 5Surgical Oncology, Ludwik Rydygier’s Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland. 6Department of Surgical Oncology, Oncology Center - Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. 7Department of Oncological, Transplant and General Surgery, Medical University of Gdańsk, Gdańsk, Poland. 8Department of Tumor Pathology and Pathomorphology, Oncology Center – Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. 9Department of Clinical Pathomorphology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland. 10These authors contributed equally: Magdalena Wójcik, Ulana Juhas and Elyas Mohammadi. 11These authors jointly supervised this work: Natalia Filipowicz and Jan P. Dumanski. *[email: natalia.filipowicz@gumed.edu.pl](email: natalia.filipowicz@gumed.edu.pl); [jan.dumanski@ig","cbCaitJ3kNvNhAug","https://ap.wps.com/l/cbCaitJ3kNvNhAug","pdf",2156889,12,"English","# Background\n## Sex differences and LOY hypothesis\n# Study design and analysis\n## Measuring LOY in blood, TME, and tissue\n## scRNA-seq LOY score and immune gene expression\n# Key findings\n## LOY frequency in Tregs\n## PDCD1, TIGIT, IKZF2 links\n# Implications\n## Possible role in Treg suppressive phenotype\n## Potential effect on immunotherapy response","[{\"question\":\"What question does the study address about colorectal cancer?\",\"answer\":\"It examines whether loss of chromosome Y (LOY) in the tumor micro-environment contributes to colorectal cancer development.\"},{\"question\":\"Which immune cell population showed the highest LOY frequency in the tumor micro-environment?\",\"answer\":\"Regulatory T lymphocytes (Tregs) in the tumor micro-environment had the highest LOY frequency, reported as 22%.\"},{\"question\":\"How is LOY related to immune checkpoint signaling in Tregs?\",\"answer\":\"An LOY score from scRNA-seq correlated with higher expression of PDCD1 and TIGIT (immune checkpoint receptors), along with IKZF2 in Tregs.\"}]","Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases | PDF",1790028951,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f537d1c312272b8dfb828c654a65ace9.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4673cef4ee397b52815bc8c22d01d5b5.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3a3d0cc091ff7ab80278fc090b28e4c.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af9a87aa33f010b9d4dc041328f8930e.webp",980,1287]